WHO胰胆细胞病理报告系统诊断分类的恶性风险
本研究将334例胰腺EUS-FNA样本从PSC系统重新分类为WHO系统,计算各诊断分类的绝对恶性风险(ROM)。WHO系统中PaN-High的ROM为60.0%,PaN-Low为4.8%,较PSC系统分层更优,结论认为WHO系统改善了ROM分层。
要点
- WHO系统PaN-High的ROM为60.0%,PaN-Low为4.8%。
- WHO系统将低级别恶性肿瘤归入「恶性」类别。
- WHO系统较PSC系统在ROM分层上有改善。
核心结论
- WHO国际系统较PSC系统在相关恶性风险分层上有所改善。
主要发现
- WHO系统绝对ROM:不足/不充分/无诊断7.7%,良性/恶性阴性1.0%,非典型28.0%,PaN-Low 4.8%,PaN-High 60.0%,可疑恶性100%,恶性100%。
- 同一队列PSC系统绝对ROM:无诊断7.7%,恶性阴性1.0%,非典型28.0%,肿瘤性:良性0.0%,肿瘤性:其他30.3%,可疑恶性100%,阳性或恶性100%。
关键数值与推荐
- WHO系统将肿瘤性:良性和肿瘤性:其他类别替换为胰腺肿瘤性-低级别(PaN-Low)和胰腺肿瘤性-高级别(PaN-High),按细胞异型性对肿瘤性黏液性囊肿分层。
- 低级别恶性肿瘤归入「恶性」类别,良性浆液性囊腺瘤归入「良性/阴性」类别。
临床怎么用
- 采用WHO系统对胰胆细胞病理进行诊断分类,可依据PaN-Low和PaN-High等分类的ROM指导临床管理。
局限性
- 单中心回顾性设计,样本来自2016年一年,绝对ROM基于组织学结局和/或至少6个月临床随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The World Health Organization (WHO) has proposed an updated international classification system for reporting pancreaticobiliary cytology. Substantial changes to the prior Papanicolaou Society of Cytopathology (PSC) system have been recommended. Chiefly, the "neoplastic: benign" and "neoplastic: other" categories have been replaced by 2 new categories-"pancreatic neoplasia-low-grade" (PaN-Low) and "pancreatic neoplasia-high-grade" (PaN-High)-stratifying neoplastic mucinous cysts by cytological atypia. Low-grade malignancies are placed in the "malignant" category and benign serous cystadenoma in the "benign/negative" category. Risk of malignancy (ROM) associated with the diagnostic categories of the WHO system has yet to be defined. METHODS: All patients who underwent endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for a pancreatic lesion at a single institution from January 2016 to December 2016, prospectively classified using the PSC system, were reclassified using the WHO system. Absolute ROM was determined by histologic outcome and/or clinical follow-up of at least 6 months. RESULTS: A total of 334 EUS-FNA samples from 322 patients were reviewed and reclassified. Absolute ROM for the WHO system was 7.7% for "insufficient/inadequate/nondiagnostic" category, 1.0% for "benign/negative for malignancy," 28.0% for "atypical," 4.8% for "PaN-Low," 60.0% for "PaN-High," 100% for "suspicious for malignancy," and 100% for "malignant;" the absolute ROM for the same cohort using the PSC system was 7.7% for "nondiagnostic" category, 1.0% for "negative (for malignancy)," 28.0% for "atypical," 0.0% for "neoplastic: benign," 30.3% for "neoplastic: other," 100% for "suspicious (for malignancy)," and 100% for "positive or malignant." CONCLUSIONS: The WHO international system achieves improved stratification by associated ROM compared to the PSC system.
引用
- Hoda RS, Arpin RN, Rosenbaum MW, et al. Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology. Cancer Cytopathol. 2021. PMID: 34623767. doi:10.1002/cncy.22514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。